CLDF Title
Home | Contact Us | Bookmark
    HCC   HE   HRS   NASH   PBC   THROMBOCYTOPENIA  
Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Committee Members Conference Highlights
 

HCV | AUDIOCASTS


Beginning Date

04/30/19

Ending Date

04/30/20

1.0

credits
 
Target Audience:
This educational program is targeted at physicians and other healthcare providers who specialize in the management of patients with CLD.
 
Goal Statement:
Topic-specific teleconferences presented by a Chronic Liver Disease faculty member who will review and discuss challenging cases in CLD.
 
Learning Objectives:
Upon completion of this activity, participants should be able to:

Describe current guidelines and management recommendations for patients with chronic liver disease
Utilizing current therapies, optimize treatment results for patients with chronic liver disease
Identify new therapeutic advances and assess their potential impact on clinical practice
 
Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation:
Annenberg Center for Health Sciences at Eisenhower estimates each enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™.
 
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation have no relationships to disclose.
 
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
 

Accredited by




Provided by




This activity is supported by an educational grant from AbbVie.

 

The Chronic Liver Disease Foundation (CLDF) recognizes the important role of the GI fellow in the current and future management of patients with chronic liver disorders. As most of their training is focused on gastroenterology, the CLDF hosted the first annual Liver Summit for GI Fellows in Chicago on August 10th and 11th, 2018. The meeting was designed for third-year GI Fellows nominated by the CLDF Centers of Educational Expertise and fellowship directors.
 
The Summit brought together approximately sixty third-year fellows who were interested in hepatology. In addition to state-of-the-art disease and management lectures, the program delivered important clinical practice management lectures that provided the fellows with insight into community and academic practices today and when they leave their fellowship.
 
The following teleconferences were presented by CLDF faculty to those fellows who attended the Liver Summit and have been recorded for additional viewers to receive CME credits.
 

 
RECORDED TELECONFERENCES
 
Management Challenges in HCV
 
Speaker
Bruce R. Bacon, MD
Professor of Internal Medicine
Co-Director of the Saint Louis University Liver Center
Saint Louis University School of Medicine
Saint Louis, Missouri
 
 
DISCLOSURES
Research Support: AbbVie, and Gilead Sciences, Inc.
Consultant: AbbVie, Dova Pharmaceuticals, Gilead Sciences, Inc., and Intercept Pharmaceuticals.
Speakers Bureau: AbbVie, Dova Pharmaceuticals, Gilead Sciences, Inc., and Intercept Pharmaceuticals.
 

 
Clinical Insights into the Management
of the Complications of Cirrhosis
 
Speaker
Steven L. Flamm, MD
Chief, Hepatology and Liver Transplantation
Professor of Medicine
Northwestern Feinberg School of Medicine
 
 
DISCLOSURES
Consultant / Speakers Bureau: Salix Pharmaceuticals.
 

 
Updates in the Management of NASH
 
Speaker
Zobair Younossi, MD
Falls Church, Virginia
 
 
DISCLOSURES
Consultant: BMS, Gilead, and Intercept Pharmaceuticals.
 

 
 
                               
 
HEPATITIS
HBV
HCV
HDV
 
 
HCC
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HRS
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Webcasts
Slide Library
Abstract Library
 
 
THROMBOCYTOPENIA
Webcasts
Slide Library
   
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors/Faculty
2019 GI Fellow Board of Advisors
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
             
CLDF Follow Us
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2019 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.